117 related articles for article (PubMed ID: 20067163)
1. Endothelial dysfunction in metabolic syndrome.
Cozma A; Orăşan O; Sâmpelean D; Fodor A; Vlad C; Negrean V; Rednic N; Zdrenghea D
Rom J Intern Med; 2009; 47(2):133-40. PubMed ID: 20067163
[TBL] [Abstract][Full Text] [Related]
2. Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.
Reaven GM
Panminerva Med; 2005 Dec; 47(4):201-10. PubMed ID: 16489319
[TBL] [Abstract][Full Text] [Related]
3. Hemostasis alterations in metabolic syndrome (review).
Palomo I; Alarcón M; Moore-Carrasco R; Argilés JM
Int J Mol Med; 2006 Nov; 18(5):969-74. PubMed ID: 17016629
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor-alpha induces endothelial dysfunction in the prediabetic metabolic syndrome.
Picchi A; Gao X; Belmadani S; Potter BJ; Focardi M; Chilian WM; Zhang C
Circ Res; 2006 Jul; 99(1):69-77. PubMed ID: 16741160
[TBL] [Abstract][Full Text] [Related]
5. Reciprocal relationships between abnormal metabolic parameters and endothelial dysfunction.
Han SH; Quon MJ; Koh KK
Curr Opin Lipidol; 2007 Feb; 18(1):58-65. PubMed ID: 17218834
[TBL] [Abstract][Full Text] [Related]
6. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases.
Cersosimo E; DeFronzo RA
Diabetes Metab Res Rev; 2006; 22(6):423-36. PubMed ID: 16506274
[TBL] [Abstract][Full Text] [Related]
7. Insulin resistance, metabolic syndrome and vascular diseases: update on mechanistic linkages.
Lteif A; Mather K
Can J Cardiol; 2004 Aug; 20 Suppl B():66B-76B. PubMed ID: 15309208
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of Disease: endothelial dysfunction in insulin resistance and diabetes.
Rask-Madsen C; King GL
Nat Clin Pract Endocrinol Metab; 2007 Jan; 3(1):46-56. PubMed ID: 17179929
[TBL] [Abstract][Full Text] [Related]
9. Effects of insulin resistance on endothelial progenitor cells and vascular repair.
Cubbon RM; Kahn MB; Wheatcroft SB
Clin Sci (Lond); 2009 Aug; 117(5):173-90. PubMed ID: 19630751
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular disease, metabolic syndrome and erectile dysfunction.
Müller A; Mulhall JP
Curr Opin Urol; 2006 Nov; 16(6):435-43. PubMed ID: 17053524
[TBL] [Abstract][Full Text] [Related]
11. Diabetes is a vascular disease: the role of endothelial dysfunction in pathophysiology of cardiovascular disease in diabetes.
Deedwania PC
Cardiol Clin; 2004 Nov; 22(4):505-9, v. PubMed ID: 15501619
[TBL] [Abstract][Full Text] [Related]
12. Relationship between insulin resistance and some coagulation and fibrinolytic parameters in patients with metabolic syndrome.
Ragab A; Abousamra NK; Higazy A; Saleh O
Lab Hematol; 2008; 14(1):1-6. PubMed ID: 18403313
[TBL] [Abstract][Full Text] [Related]
13. The role of obesity and its bioclinical correlates in the progression of chronic kidney disease.
Chalmers L; Kaskel FJ; Bamgbola O
Adv Chronic Kidney Dis; 2006 Oct; 13(4):352-64. PubMed ID: 17045221
[TBL] [Abstract][Full Text] [Related]
14. Endothelial and erectile dysfunction, diabetes mellitus, and the metabolic syndrome: common pathways and treatments?
Fonseca V; Jawa A
Am J Cardiol; 2005 Dec; 96(12B):13M-18M. PubMed ID: 16387560
[TBL] [Abstract][Full Text] [Related]
15. The small, dense LDL phenotype and the risk of coronary heart disease: epidemiology, patho-physiology and therapeutic aspects.
Lamarche B; Lemieux I; Després JP
Diabetes Metab; 1999 Sep; 25(3):199-211. PubMed ID: 10499189
[TBL] [Abstract][Full Text] [Related]
16. De novo synthesis of diacylglycerol in endothelium may mediate the association between PAI-1 and the insulin resistance syndrome.
McCarty MF
Med Hypotheses; 2005; 64(2):388-93. PubMed ID: 15607575
[TBL] [Abstract][Full Text] [Related]
17. Hepatic insulin resistance, metabolic syndrome and cardiovascular disease.
Meshkani R; Adeli K
Clin Biochem; 2009 Sep; 42(13-14):1331-46. PubMed ID: 19501581
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of postprandial hyperglycemia by acarbose is a promising therapeutic strategy for the treatment of patients with the metabolic syndrome.
Yamagishi S; Nakamura K; Takeuchi M
Med Hypotheses; 2005; 65(1):152-4. PubMed ID: 15893133
[TBL] [Abstract][Full Text] [Related]
19. Insulin resistance, metabolic syndrome and endothelial dysfunction.
Bigazzi R; Bianchi S
J Nephrol; 2007; 20(1):10-4. PubMed ID: 17347967
[TBL] [Abstract][Full Text] [Related]
20. Multiple abnormalities in glucose and energy metabolism and coordinated changes in levels of adiponectin, cytokines, and adhesion molecules in subjects with metabolic syndrome.
Salmenniemi U; Ruotsalainen E; Pihlajamäki J; Vauhkonen I; Kainulainen S; Punnonen K; Vanninen E; Laakso M
Circulation; 2004 Dec; 110(25):3842-8. PubMed ID: 15596567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
